| Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features N Zmora, G Zilberman-Schapira, J Suez, U Mor, M Dori-Bachash, ... Cell 174 (6), 1388-1405. e21, 2018 | 1248 | 2018 |
| Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT J Suez, N Zmora, G Zilberman-Schapira, U Mor, M Dori-Bachash, ... Cell 174 (6), 1406-1423. e16, 2018 | 938 | 2018 |
| A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation E Kotler, O Shani, G Goldfeld, M Lotan-Pompan, O Tarcic, A Gershoni, ... Molecular cell 71 (1), 178-190. e8, 2018 | 242 | 2018 |
| RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation G Fuchs, E Shema, R Vesterman, E Kotler, Z Wolchinsky, S Wilder, ... Molecular cell 46 (5), 662-673, 2012 | 217 | 2012 |
| Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival DR Bublik, S Bursać, M Sheffer, I Oršolić, T Shalit, O Tarcic, E Kotler, ... Proceedings of the National Academy of Sciences 114 (4), E496-E505, 2017 | 66 | 2017 |
| Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response KL McNamara, JL Caswell-Jin, R Joshi, Z Ma, E Kotler, GR Bean, ... Nature cancer 2 (4), 400-413, 2021 | 60 | 2021 |
| N‐Methylation of isopeptide bond as a strategy to resist deubiquitinases M Haj‐Yahya, N Eltarteer, S Ohayon, E Shema, E Kotler, M Oren, A Brik Angewandte Chemie 46 (124), 11703-11707, 2012 | 51 | 2012 |
| Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) SA Hurvitz, JL Caswell-Jin, KL McNamara, JJ Zoeller, GR Bean, ... Nature communications 11 (1), 5824, 2020 | 46 | 2020 |
| Deterministic evolution and stringent selection during preneoplasia K Karlsson, MJ Przybilla, E Kotler, A Khan, H Xu, K Karagyozova, ... Nature 618 (7964), 383-393, 2023 | 33* | 2023 |
| p53 mutations promote proteasomal activity M Oren, E Kotler Nature cell biology 18 (8), 833-835, 2016 | 16 | 2016 |
| Functional characterization of the p53 “mutome” E Kotler, E Segal, M Oren Molecular & cellular oncology 5 (6), e1511207, 2018 | 5 | 2018 |
| APOBEC3G protects the genome of human cultured cells and mice from radiation‐induced damage Y Britan‐Rosich, J Ma, E Kotler, F Hassan, A Botvinnik, Y Smith, O Moshel, ... The FEBS Journal 290 (7), 1822-1839, 2023 | 2 | 2023 |
| The helix twist: damage and repair follows the DNA Minor groove E Kotler, E Segal Cell 175 (4), 902-904, 2018 | 2 | 2018 |
| Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the … JL Caswell-Jin, KL McNamara, J Dering, HW Chen, R Dichmann, A Perez, ... Cancer research (Chicago, Ill.) 80 (4_Supplement), P4-P4-07-01, 2020 | | 2020 |
| Tumoral p53 mutations differentially mediate poor T-cell infiltration and autologous T-cell killing in preclinical models DA Silverman, E Ashkin, B Whitfield, S Punt, SZ Manrique, Y Wang, ... Cancer Research 79 (13_Supplement), 2372-2372, 2019 | | 2019 |
| Comprehensive characterization of the functional effects of p53 mutations E Kotler PQDT-Global, 2019 | | 2019 |
| Erratum to RNF20 and USP44 Regulate Stem Cell Differentiation by Modulating H2B Monoubiquitylation [Molecular Cell, 46,(2012), 662-673] G Fuchs, E Shema, R Vesterman, E Kotler, Z Wolchinsky, S Wilder, ... Molecular Cell 60 (2), 338, 2015 | | 2015 |
